VIA
XERS icon

Virtus Investment Advisers’s Xeris Biopharma Holdings XERS Stock Holding History

Virtus Investment Advisers’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.36M Buy
171,264
+133,234
+350% +$851K 0.32% 143
2026
Q1 		$221K Buy
38,030
+928
+3% +$6.15K 0.06% 330
2025
Q4 		$291K Buy
37,102
+11,358
+44% +$89.4K 0.08% 262
2025
Q3 		$210K Buy
25,744
+4,470
+21% +$29.7K 0.06% 255
2025
Q2 		$99.3K Sell
21,274
-27,014
-56% -$124K 0.03% 336
2025
Q1 		$265K Buy
+48,288
New +$195K 0.07% 250

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Virtus Investment Advisers's XERS Position: Q2 2026 in Review

Virtus Investment Advisers increased its Xeris Biopharma Holdings (XERS) stake by 350% in Q2 2026, buying an estimated $851K and bringing the position to 171,264 shares worth $1.36M. The position accounts for 0.32% of the portfolio, ranked #143.

Virtus Investment Advisers first reported a position in XERS in Q1 2025 and has held it in 6 quarters since. 240 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

  • Virtus Investment Advisers held 171,264 shares of Xeris Biopharma Holdings worth $1.36M as of Q2 2026.
  • Virtus Investment Advisers bought 133,234 Xeris Biopharma Holdings shares in Q2 2026, an estimated $851K.
  • Xeris Biopharma Holdings made up 0.32% of Virtus Investment Advisers's portfolio in Q2 2026, its #143 holding.
  • Virtus Investment Advisers first reported a position in Xeris Biopharma Holdings in Q1 2025 and has held it in 6 quarters since.
  • 240 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on Virtus Investment Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.